Brown Advisory Inc. Has $282,000 Stake in The Chemours Company (NYSE:CC)

Brown Advisory Inc. boosted its stake in shares of The Chemours Company (NYSE:CC) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,874 shares of the specialty chemicals company’s stock after acquiring an additional 1,174 shares during the quarter. Brown Advisory Inc.’s holdings in Chemours were worth $282,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its holdings in Chemours by 6.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,302,272 shares of the specialty chemicals company’s stock valued at $22,008,000 after purchasing an additional 73,220 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in shares of Chemours during the fourth quarter worth $334,000. Raymond James Financial Inc. acquired a new stake in shares of Chemours in the fourth quarter valued at $2,283,000. Swiss National Bank raised its holdings in shares of Chemours by 1.0% in the fourth quarter. Swiss National Bank now owns 293,500 shares of the specialty chemicals company’s stock valued at $4,960,000 after buying an additional 2,800 shares during the last quarter. Finally, Corient Private Wealth LLC raised its holdings in shares of Chemours by 4.7% in the fourth quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company’s stock valued at $227,000 after buying an additional 604 shares during the last quarter. 76.26% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CC shares. Barclays reduced their target price on shares of Chemours from $16.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 28th. Wall Street Zen lowered Chemours from a “hold” rating to a “sell” rating in a research report on Wednesday, May 21st. UBS Group dropped their target price on Chemours from $18.00 to $17.00 and set a “buy” rating for the company in a research report on Wednesday, May 7th. Mizuho upped their price target on Chemours from $13.00 to $16.00 and gave the company an “outperform” rating in a research note on Tuesday. Finally, Royal Bank Of Canada lifted their price objective on Chemours from $14.00 to $15.00 and gave the stock an “outperform” rating in a research report on Thursday, July 3rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $17.44.

Insider Buying and Selling at Chemours

In other Chemours news, insider Damian Gumpel purchased 13,400 shares of the stock in a transaction on Monday, June 2nd. The shares were purchased at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the purchase, the insider owned 123,879 shares of the company’s stock, valued at approximately $1,142,164.38. This represents a 12.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shane Hostetter acquired 4,450 shares of the firm’s stock in a transaction dated Monday, May 19th. The stock was bought at an average price of $11.28 per share, with a total value of $50,196.00. Following the acquisition, the chief financial officer directly owned 59,694 shares in the company, valued at $673,348.32. This represents a 8.06% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 25,672 shares of company stock valued at $251,573 in the last 90 days. 0.47% of the stock is currently owned by corporate insiders.

Chemours Trading Up 0.6%

NYSE:CC opened at $13.25 on Thursday. The business’s 50-day moving average price is $11.48 and its two-hundred day moving average price is $13.88. The company has a current ratio of 1.75, a quick ratio of 0.83 and a debt-to-equity ratio of 7.01. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 66.27 and a beta of 1.65. The Chemours Company has a 1-year low of $9.13 and a 1-year high of $25.38.

Chemours (NYSE:CC) last issued its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The business had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.36 billion. Chemours had a net margin of 0.54% and a return on equity of 23.82%. Chemours’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.32 earnings per share. On average, equities analysts expect that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, June 16th. Stockholders of record on Monday, May 19th were given a $0.0875 dividend. This represents a dividend yield of 3.17%. The ex-dividend date of this dividend was Friday, May 16th. Chemours’s dividend payout ratio is presently 175.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.